Medacta Group's market value is the price at which a share of Medacta Group trades on a public exchange. It measures the collective expectations of Medacta Group SA investors about its performance. Medacta Group is selling for under 147.80 as of the 16th of February 2026; that is 0.54% down since the beginning of the trading day. The stock's lowest day price was 147.2. With this module, you can estimate the performance of a buy and hold strategy of Medacta Group SA and determine expected loss or profit from investing in Medacta Group over a given investment horizon. Check out Medacta Group Correlation, Medacta Group Volatility and Medacta Group Performance module to complement your research on Medacta Group.
Understanding that Medacta Group's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medacta Group represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Medacta Group's market price signifies the transaction level at which participants voluntarily complete trades.
Medacta Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medacta Group's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medacta Group.
0.00
11/18/2025
No Change 0.00
0.0
In 3 months and 1 day
02/16/2026
0.00
If you would invest 0.00 in Medacta Group on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Medacta Group SA or generate 0.0% return on investment in Medacta Group over 90 days. Medacta Group is related to or competes with Siegfried Holding, Tecan Group, BB Biotech, Galenica Sante, Ypsomed Holding, Medartis Holding, and SKAN Group. Medacta Group is entity of Switzerland. It is traded as Stock on SW exchange. More
Medacta Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medacta Group's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medacta Group SA upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medacta Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medacta Group's standard deviation. In reality, there are many statistical measures that can use Medacta Group historical prices to predict the future Medacta Group's volatility.
At this stage we consider Medacta Stock to be very steady. Medacta Group SA has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Medacta Group, which you can use to evaluate the volatility of the firm. Please verify Medacta Group's Downside Deviation of 1.72, risk adjusted performance of 0.0467, and Mean Deviation of 1.19 to check out if the risk estimate we provide is consistent with the expected return of 0.0111%. The company secures a Beta (Market Risk) of 0.0887, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medacta Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medacta Group is expected to be smaller as well. Medacta Group SA right now secures a risk of 1.65%. Please verify Medacta Group SA coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to decide if Medacta Group SA will be following its current price movements.
Auto-correlation
-0.53
Good reverse predictability
Medacta Group SA has good reverse predictability. Overlapping area represents the amount of predictability between Medacta Group time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medacta Group SA price movement. The serial correlation of -0.53 indicates that about 53.0% of current Medacta Group price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.53
Spearman Rank Test
-0.37
Residual Average
0.0
Price Variance
59.78
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.